Omeros Corp (OMER): EPS (Basic)
-$0.05
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.05 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$2.70 | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$1.88 | n/m | 2026-03-31, From 2023-01-01 |
| 2022-12-31 | $0.76 | -75.6% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $3.12 | n/m | 2024-04-01, From 2021-01-01 |
| 2020-12-31 | -$2.41 | n/m | 2023-03-13, From 2020-01-01 |
| 2019-12-31 | -$1.71 | n/a | 2022-03-01, From 2019-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Omeros Corp (OMER) | 2025-12-31 | -$0.05 | n/m |
| Sionna Therapeutics, Inc. (SION) | 2025-12-31 | -$1.88 | n/m |
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | -$4.53 | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$1.74 | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$0.80 | n/m |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$1.12 | n/m |
| Rocket Pharmaceuticals, Inc. (RCKT) | 2025-12-31 | -$2.01 | n/m |
| Amylyx Pharmaceuticals, Inc. (AMLX) | 2025-12-31 | -$1.53 | n/m |
| ArriVent BioPharma, Inc. (AVBP) | 2025-12-31 | -$4.32 | n/m |
Compare OMER, SION, PRTA, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗